Finance

Lists
688506:SHA
Sichuan Biokin Pharmaceutical Co Ltd
CN¥226.60
-0.61%
(-1.40) 1D
Oct 13, 3:00:01 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688506...
Open
CN¥225.95
High
CN¥229.44
Low
CN¥222.71
Mkt. cap
94.68B
Avg. vol.
1.69M
Volume
1.16M
52-wk high
CN¥404.00
52-wk low
CN¥200.10
EPS
-CN¥3.79
No. of employees
3K
Open
CN¥225.95
High
CN¥229.44
Low
CN¥222.71
Mkt. cap
94.68B
Avg. vol.
1.69M
Volume
1.16M
52-wk high
CN¥404.00
52-wk low
CN¥200.10
EPS
-CN¥3.79
No. of employees
3K
News stories
From web sources and news partners
Profile
Sichuan Biokin Pharmaceutical Co., Ltd. is a publicly listed Chinese biopharmaceutical company that is headquartered in Chengdu, Sichuan. Wikipedia
About Sichuan Biokin Pharmaceutical Co Ltd
CEO-
Employees3.43K
FoundedAug 23, 1996
Headquarters-
SectorPharmaceutical industry
Websiteen.baili-pharm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.89B
454.22M
94.59M
92.75M
Cost of goods sold
43.74M
115.66M
43.37M
59.34M
Cost of revenue
43.74M
115.66M
43.37M
59.34M
Research and development expenses
733.75M
741.34M
694.76M
787.93M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
144.15M
169.94M
126.35M
113.01M
Operating expense
862.71M
926.05M
813.01M
892.42M
Total operating expenses
906.45M
1.04B
856.38M
951.76M
Operating income
988.25M
-587.49M
-761.79M
-859.01M
Other non operating income
-68.11M
68.05M
-142.74M
142.75M
EBT including unusual items
942.32M
-535.84M
-776.15M
-901.42M
EBT excluding unusual items
977.50M
-586.93M
-841.61M
-965.12M
Income tax expense
318.88M
23.26M
-1.59M
-38.76M
Effective tax rate
33.84%
-4.34%
0.21%
4.30%
Other operating expenses
-15.12M
14.55M
-7.43M
-9.01M
Net income
623.44M
-559.10M
-774.56M
-862.66M
Net profit margin
32.90%
-123.09%
-818.89%
-930.11%
Earnings per share
-
-
-
-
Interest and investment income
54.03M
56.43M
89.48M
36.67M
Interest expense
-24.43M
-26.18M
-26.56M
-29.06M
Net interest expenses
29.60M
30.26M
62.92M
7.62M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.01B
-567.21M
-741.51M
-836.43M
Gain or loss from assets sale
1.06K
-1.06K
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps